| 08:00 AM – 09:00 AM |
SESSION 1: Free papers |
| 09:00 AM – 11.30 AM |
SESSION 2 : BENIGN BONE TUMOURS |
| 09:00 – 09:14 AM |
Pitfalls in diagnosis of benign bone tumours – is biopsy mandatory? |
| 09:14 – 09:28 AM |
Non surgical interventions in benign bone tumours |
| 09:28 – 09:42 AM |
Surgical treatment in ABC – is it justified?? |
| 09:42 – 09:54 AM |
Video presentation – GCT curettage |
| 09:54 – 10:08 AM |
How far can you extend the boundaries of curettage in appendicular GCT |
| 10:08- 10:22 AM |
Current role of Denosumab in GCT |
| 10:22- 10: 36 AM |
GCT of spine and sacrum – How best to manage |
| 10:36 – 11:30 AM |
Panel – Benign Bone Tumours |
| 11:30 – 11:40 AM |
Lamp lighting and Inaugration |
| 11:40 – 11:50 AM |
Tea |
| 11:50 – 12:30 PM |
IMSOS Oration |
| 12:30 – 01:30 PM |
Gold Medal Papers |
| 01:30 – 02:15 PM |
Lunch |
| 02:15 – 04:00 PM |
SESSION 3: ROUND CELL SARCOMAS |
| 02:15 – 02:29 PM |
Spectrum of round cell sarcomas and their outcome |
| 02:29 – 02:43 PM |
Dose escalation for definitive radiotherapy in Ewing’s – Impact on disease control |
| 02:43 – 02:57 PM |
Chemotherapy in non-metastatic Ewing’s sarcoma- standard of care |
| 02:57 – 03:11 PM |
Impact of Radiation therapy on reconstruction options in Ewings Sarcoma |
| 03:11 – 03:25 PM |
Primary Metastatic Ewings – Newer advances |
| 03:25 – 04:15 PM |
Panel – Ewing’s Sarcoma |
| 04:15 – 04:30 PM |
Tea |
| 04:30 – 05:15 PM |
SESSION 4: PROSTHETIC JOINT INFECTION |
| 04:30 – 04:44 PM |
Antibiotic prophylaxis in Orthopaedic Oncology – What Parity taught us?? |
| 04:44 – 04:58 PM |
Factors influencing outcome of SSI in patients managed with Endoprosthesis |
| 04:58 – 05:15 PM |
DAIR vs 2 stage revision – How do I choose and appropriate antibiotic guidleines? |
| 05:15 – 06:15 PM |
SESSION 5 : Role of Multidisciplinary tumor board – form diagnosis to treatment – Case based discussions |
| 06:00 – 07:30 PM |
IMSOS General Body Meeting |
| 07:30 PM Onwards |
Gala dinner |
